Finance

Lists
RNXT:NASDAQ
RenovoRx Inc
$1.69
-3.98%
(-0.070) 1D
$1.65
-2.37% (-0.040)
After hours
Closed: Sep 14, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RNXT...
Open
$1.75
High
$1.85
Low
$1.66
Mkt. cap
76.27M
Avg. vol.
1.17M
Volume
577.92K
52-wk high
$2.59
52-wk low
$0.70
EPS
-$0.31
Beta
1.12
Shares outstanding
45.13M
No. of employees
17
Open
$1.75
High
$1.85
Low
$1.66
Mkt. cap
76.27M
Avg. vol.
1.17M
Volume
577.92K
52-wk high
$2.59
52-wk low
$0.70
EPS
-$0.31
Beta
1.12
Shares outstanding
45.13M
No. of employees
17
News stories
From web sources and news partners
About RenovoRx Inc
CEO-
Employees17
Founded2009
Headquarters-
SectorBiotechnology
Websiterenovorx.com
Analyst ratings
Based on 4 analysts giving stock ratings to RNXT in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for RNXT in the last 3 months.
Highest
Current $1.69
$14.50 (+757.99%)
Average
$7.13 (+321.89%)
Lowest
$3.00 (+77.51%)
Analyst
Recommendation
Action
Price target
Projected
Date
Edward Woo
Ascendiant
Buy
Maintained
$14.50
+758%
08/27/2026
Justin Walsh
JonesTrading
Buy
Reiterated
$8.00
+373.4%
08/19/2026
Swayampakula Ramakanth
H.C. Wainwright
Buy
Maintained
$3.00
+77.5%
08/14/2026
Scott Henry
Alliance Global Partners
Buy
Maintained
$3.00
+77.5%
08/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
266.00K
238.00K
563.00K
909.00K
Cost of goods sold
53.00K
28.00K
84.00K
143.00K
Cost of revenue
53.00K
28.00K
84.00K
143.00K
Research and development expenses
1.58M
1.00M
1.23M
1.20M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.73M
2.23M
2.72M
2.92M
Operating expense
3.31M
3.23M
3.95M
4.12M
Total operating expenses
3.37M
3.26M
4.03M
4.26M
Operating income
-3.10M
-3.02M
-3.47M
-3.35M
Other non operating income
175.00K
506.00K
-97.00K
350.00K
EBT including unusual items
-2.91M
-2.94M
-3.52M
-2.91M
EBT excluding unusual items
-2.81M
-2.44M
-3.52M
-2.91M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.91M
-2.94M
-3.52M
-2.91M
Net profit margin
-1,094.74%
-1,235.71%
-625.40%
-320.24%
Earnings per share
-0.08
-0.08
-0.08
-0.05
Interest and investment income
113.00K
75.00K
45.00K
90.00K
Interest expense
-
-
-
-
Net interest expenses
113.00K
75.00K
45.00K
90.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.10M
-3.02M
-3.47M
-3.34M
Gain or loss from assets sale
-
-
-
2.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps